Aardvark Therapeutics

AARDNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$172.885 M

$7.90 +8.22%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$57.6M

Loss-making

Shares outstanding

21,816,385

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#275Oramed PharmaceuticalsORMP$178.9M
#276Journey MedicalDERM$177.0M
#277Aardvark TherapeuticsAARD$172.9M
#278NkartaNKTX$172.4M
#279OnKure TherapeuticsOKUR$167.7M

Where these numbers come from

Share counts and financials for Aardvark Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.